These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 5462284)

  • 1. Effects of propranolol on response to exercise in hypertrophic obstructive cardiomyopathy.
    Edwards RH; Kristinsson A; Warrell DA; Goodwin JF
    Br Heart J; 1970 Mar; 32(2):219-25. PubMed ID: 5462284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated response to exercise in patients with hypertrophic obstructive cardiomyopathy and effect of beta-adrenergic blockade on oxygen transport.
    Edwards RH; Kristinsson A; Warrell DA
    Br Heart J; 1969 May; 31(3):390. PubMed ID: 4396140
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hemodynamic effects of medical and surgical therapy of hypertrophic obstructive cardiomyopathy (author's transl)].
    Lösse B; Kuhn H; Krönert H; Rafflenbeul D; Kirschner P; Schulte HD; Loogen F
    Z Kardiol; 1980 Jul; 69(7):470-7. PubMed ID: 7192456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Left ventricular function at rest and during exercise and the effects of propranolol in patients with hypertrophic cardiomyopathy].
    Amano K; Sakamoto T; Sugimoto T
    J Cardiol Suppl; 1987; 16():35-51. PubMed ID: 3509682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertrophic subaortic stenosis. Clinical and hemodynamic effects of long-term propranolol therapy.
    Stenson RE; Flamm MD; Harrison DC; Hancock EW
    Am J Cardiol; 1973 Jun; 31(6):763-73. PubMed ID: 4735938
    [No Abstract]   [Full Text] [Related]  

  • 6. Amelioration of angina pectoris in idiopathic hypertrophic subaortic stenosis with beta-adrenergic blockade.
    Cohen LS; Braunwald E
    Circulation; 1967 May; 35(5):847-51. PubMed ID: 6067064
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term medical management of hypertrophic cardiomyopathy: usefulness of propranolol.
    Frank MJ; Abdulla AM; Watkins LO; Prisant L; Stefadouros MA
    Eur Heart J; 1983 Nov; 4 Suppl F():155-64. PubMed ID: 6686531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic studies of beta blockade in hypertrophic obstructive cardiomyopathy.
    Swanton RH; Brooksby IA; Jenkins BS; Webb-Peploe MM
    Eur J Cardiol; 1977 Jun; 5(4):327-41. PubMed ID: 196858
    [No Abstract]   [Full Text] [Related]  

  • 9. Propranolol.
    Shand DG
    Dis Mon; 1974 Oct; ():1-31. PubMed ID: 4606956
    [No Abstract]   [Full Text] [Related]  

  • 10. Exercise performance in hypertrophic cardiomyopathies.
    Lösse B; Kuhn H; Loogen F; Schulte HD
    Eur Heart J; 1983 Nov; 4 Suppl F():197-208. PubMed ID: 6686536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hemodynamic effects of propranolol on obstructive myocardiopathy].
    Ourbak P; Bourdarias JP; Cachin JC; Rocha P; Scebat L; Lenègre J
    Arch Mal Coeur Vaiss; 1971 Mar; 64(3):352-71. PubMed ID: 4397007
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of acute administration of propranolol on ventricular function in hypertrophic obstructive cardiomyopathy measured by non-invasive techniques.
    Saenz de la Calzada C; Ziady GM; Hardarson T; Curiel R; Goodwin JF
    Br Heart J; 1976 Aug; 38(8):798-803. PubMed ID: 987791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic long-term results after medical and surgical therapy of hypertrophic cardiomyopathies.
    Lösse B; Loogen F; Schulte HD
    Z Kardiol; 1987; 76 Suppl 3():119-30. PubMed ID: 3433864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind trial of propranolol and practolol in hypertrophic cardiomyopathy.
    Hubner PJ; Ziady GM; Lane GK; Hardarson T; Scales B; Oakley CM; Goodwin JF
    Br Heart J; 1973 Nov; 35(11):1116-23. PubMed ID: 4586631
    [No Abstract]   [Full Text] [Related]  

  • 15. Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy.
    Rosing DR; Kent KM; Maron BJ; Condit J; Epstein SE
    Clin Invest Med; 1980; 3(1-2):195-203. PubMed ID: 7009000
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of propranolol and disopyramide on left ventricular function at rest and during exercise in hypertrophic cardiomyopathy.
    Hartmann A; Kühn J; Hopf R; Klepzig H; Standke R; Kober G; Maul FD; Hör G; Kaltenbach M
    Cardiology; 1992; 80(2):81-8. PubMed ID: 1611637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of propranolol on myocardial oxygen consumption, substrate extraction, and haemodynamics in hypertrophic obstructive cardiomyopathy.
    Thompson DS; Naqvi N; Juul SM; Swanton RH; Coltart DJ; Jenkins BS; Webb-Peploe MM
    Br Heart J; 1980 Nov; 44(5):488-98. PubMed ID: 7192151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of propranolol on respiratory function and exercise tolerance in patients with chronic obstructive lung disease.
    Nordstrom LA; MacDonald F; Gobel FL
    Chest; 1975 Mar; 67(3):287-92. PubMed ID: 1112122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treadmill exercise testing in patients with idiopathic cardiomyopathy (author's transl)].
    Sakamoto S; Yasuda H; Honma H; Kudo T; Mikami T
    Hokkaido Igaku Zasshi; 1980 Jan; 55(1):15-22. PubMed ID: 7190956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic effects of verapamil and propranolol during submaximal endurance exercise in patients with essential hypertension.
    van Baak MA; Böhm RO; Petri J; Rahn KH
    Int J Sports Med; 1987 Aug; 8(4):270-4. PubMed ID: 3667024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.